Neuphoria Therapeutics Inc. (NEUP) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $77.2K | +100.5% |
| 2024 | -$14.68M | -0.3% |
| 2023 | -$14.64M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $77.2K | +100.5% |
| 2024 | -$14.68M | -0.3% |
| 2023 | -$14.64M | — |